Keywords: akela, sees, positive, ph, ii, results, its

Akela sees positive Ph II results with its GHRA

Article | 19 November 2007

Print This

Akela Pharma, a Canadian drug development company focused on therapies for the inhalation and pain markets, has announced positive final ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in